百奥泰生物制药股份有限公司 2025年第三季度报告

Core Viewpoint - The company, Bai'ao Tai Biopharmaceutical Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, with no significant omissions or misleading statements [2][3]. Financial Data Summary - The financial statements for the third quarter are unaudited, covering the period from the beginning to the end of the quarter [3][6]. - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3][4]. - The company confirms that there were no significant changes in the financial indicators compared to previous periods [5][6]. Shareholder Information - The report includes details about the total number of ordinary shareholders and the top ten shareholders, although specific numbers are not provided [5][6]. - There are no changes reported regarding the participation of major shareholders in securities lending activities [5][6]. Other Important Information - The company has not identified any additional significant information regarding its operational performance during the reporting period [5][6]. - The financial statements include the consolidated balance sheet, profit and cash flow statements for the period from January to September 2025, all of which are unaudited [6][7].